Advertisement
Canada markets open in 4 hours 48 minutes

  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CAD/USD

    0.7314
    +0.0016 (+0.23%)
     

  • CRUDE OIL

    83.15
    +0.34 (+0.41%)
     

  • Bitcoin CAD

    87,280.98
    -3,714.62 (-4.08%)
     

  • CMC Crypto 200

    1,363.05
    -19.53 (-1.41%)
     

  • GOLD FUTURES

    2,338.70
    +0.30 (+0.01%)
     

  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • NASDAQ futures

    17,477.50
    -187.00 (-1.06%)
     

  • VOLATILITY

    16.19
    +0.22 (+1.38%)
     

  • FTSE

    8,093.39
    +53.01 (+0.66%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • CAD/EUR

    0.6816
    -0.0003 (-0.04%)
     

InvestmentPitch Media Video Discusses THC BioMed's Revenue which Exceeded $1 Million in the First Quarter with Net Income of $689,000 - Video Available on Investmentpitch.com

Newsfile Corp.

Vancouver, British Columbia--(Newsfile Corp. - November 27, 2019) - THC BioMed (CSE:THC) (OTCQB: THCBF) (FSE: TFHD), a licensed producer of medical and recreational cannabis, reported revenues of $1,045,000 in the first quarter of the current fiscal year. In addition to increasing revenues by 274% compared to the first quarter in the previous fiscal period, the company also generated net income of $689,000.

InvestmentPitch.com has produced a "video" which discusses this news. If this link is not enabled, please visit www.InvestmentPitch.com and enter "THC BioMed" in the search box. 



Cannot view this video? Visit:
http://www.investmentpitch.com/video/0_iyvs29tu/THC-BioMed-exceeds-1-million-in-revenues-in-the-first-quarter-of-the-current-fiscal-year

ADVERTISEMENT

John Miller, President and CEO, stated: "We are proud to report that we surpassed the $1,000,000 revenue mark for the first three months of our fiscal year. Our financial statements for Q1 2020 reflect the improvements we have realized in all key indicators of economic progress. Over the last year, we have completed and started using new grow rooms to increase our output. Our focus on high quality, indoor-grown cannabis at reasonable prices has made our cannabis a best seller. These results demonstrate the vision and abilities of our management team and we expect to continue this high level of performance going forward."

The company generated these results with an average selling price of $4.20 per gram to both medical patients and recreational buyers, such as the Ontario Cannabis Store and B.C. Cannabis Stores, much less than the average price reported by other Licensed Producers.

Highlights of the quarter include an amendment to its license to include the production and sales of cannabis edibles, topicals and extracts. The company submitted a new product application to Health Canada for Pure Cannabis Sticks, which are filtered, paper cylinders filled with pure THC BioMed cannabis that will be manufactured using THC BioMed's automated production machine.

The company's automated cigarette manufacturing plant, which is capable of producing up to 5,000 cigarettes per minute, has been installed at THC BioMed's flagship Acland Road location in Kelowna, British Columbia. Each Pure Cannabis Stick, which is intended for a single-use session, will come in packages of 3 and 20 sticks. The natural, rapidly degrading and commercial-quality filters, made using raw materials including flax, cotton, and manila hemp, with no artificial compounds, are for convenience only and are intended to prevent loose cannabis from getting into a user's mouth. If approved, the company intends to discuss co-manufacturing agreements with larger Licensed Producers and manufacture the product on their behalf and has already received expressions of interest from some Licensed Producers.

The company also submitted a new product application to Health Canada for THC Kiss, an alternative brand new cannabis beverage product. To increase grow capacity, THC BioMed acquired an additional strata lot at its production facility. THC BioMed currently offers 21 medical cannabis strains, including 4 proprietary strains and has supply agreements with the provinces of Ontario, Saskatchewan and British Columbia.

For more information, please visit www.THCbiomed.com, contact John Miller, President & CEO, at 1-844-THCMEDS or email info@THCbiomed.com.

About InvestmentPitch Media

Investmentpitch Media leverages the power of video, which together with its extensive distribution, positions a company's story ahead of the 1,000's of companies seeking awareness and funding from the financial community. The company specializes in producing short videos based on significant news releases, research reports and other content of interest to investors.

CONTACT:

InvestmentPitch Media
Barry Morgan, CFO
bmorgan@investmentpitch.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/50159